|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61K 31/196 | |||
| A61K 39/395 | |||
| A61P 5/00 | |||
| A61K 45/06 |
| (11) | Number of the document | 2114432 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07854968.0 |
| Date of filing the European patent application | 2007-12-05 | |
| (97) | Date of publication of the European application | 2009-11-11 |
| (45) | Date of publication and mention of the grant of the patent | 2014-07-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/086550 |
| Date | 2007-12-05 |
| (87) | Number | WO 2008/070743 |
| Date | 2008-06-12 |
| (30) | Number | Date | Country code |
| 868716 P | 2006-12-05 | US |
| (72) |
PRUSSAK, Charles E., US
|
| (73) |
Memgen LLC,
402 West Broadway, Suite 400, San Diego, CA 92101,
US
|
| (54) | METHODS OF INCREASING CANCER SENSITIVITY TO CHEMOTHERAPEUTIC AGENTS USING CHIMERIC ISF35 |
| METHODS OF INCREASING CANCER SENSITIVITY TO CHEMOTHERAPEUTIC AGENTS USING CHIMERIC ISF35 |